S&P 500   3,257.34 (-1.16%)
DOW   28,656.25 (-1.15%)
QQQ   219.09 (-1.62%)
AAPL   310.78 (-2.37%)
MSFT   163.15 (-1.15%)
GOOGL   1,434.66 (-2.15%)
AMZN   1,838.52 (-1.24%)
CGC   21.90 (-3.31%)
NVDA   241.33 (-3.66%)
BABA   207.29 (-3.02%)
MU   55.77 (-3.45%)
GE   11.54 (-1.54%)
TSLA   554.30 (-1.86%)
AMD   49.59 (-1.51%)
T   38.55 (+0.13%)
ACB   1.93 (-3.02%)
F   8.93 (-0.78%)
NFLX   344.87 (-2.35%)
BAC   33.11 (-1.31%)
DIS   136.96 (-2.23%)
GILD   63.71 (+0.89%)
S&P 500   3,257.34 (-1.16%)
DOW   28,656.25 (-1.15%)
QQQ   219.09 (-1.62%)
AAPL   310.78 (-2.37%)
MSFT   163.15 (-1.15%)
GOOGL   1,434.66 (-2.15%)
AMZN   1,838.52 (-1.24%)
CGC   21.90 (-3.31%)
NVDA   241.33 (-3.66%)
BABA   207.29 (-3.02%)
MU   55.77 (-3.45%)
GE   11.54 (-1.54%)
TSLA   554.30 (-1.86%)
AMD   49.59 (-1.51%)
T   38.55 (+0.13%)
ACB   1.93 (-3.02%)
F   8.93 (-0.78%)
NFLX   344.87 (-2.35%)
BAC   33.11 (-1.31%)
DIS   136.96 (-2.23%)
GILD   63.71 (+0.89%)
S&P 500   3,257.34 (-1.16%)
DOW   28,656.25 (-1.15%)
QQQ   219.09 (-1.62%)
AAPL   310.78 (-2.37%)
MSFT   163.15 (-1.15%)
GOOGL   1,434.66 (-2.15%)
AMZN   1,838.52 (-1.24%)
CGC   21.90 (-3.31%)
NVDA   241.33 (-3.66%)
BABA   207.29 (-3.02%)
MU   55.77 (-3.45%)
GE   11.54 (-1.54%)
TSLA   554.30 (-1.86%)
AMD   49.59 (-1.51%)
T   38.55 (+0.13%)
ACB   1.93 (-3.02%)
F   8.93 (-0.78%)
NFLX   344.87 (-2.35%)
BAC   33.11 (-1.31%)
DIS   136.96 (-2.23%)
GILD   63.71 (+0.89%)
S&P 500   3,257.34 (-1.16%)
DOW   28,656.25 (-1.15%)
QQQ   219.09 (-1.62%)
AAPL   310.78 (-2.37%)
MSFT   163.15 (-1.15%)
GOOGL   1,434.66 (-2.15%)
AMZN   1,838.52 (-1.24%)
CGC   21.90 (-3.31%)
NVDA   241.33 (-3.66%)
BABA   207.29 (-3.02%)
MU   55.77 (-3.45%)
GE   11.54 (-1.54%)
TSLA   554.30 (-1.86%)
AMD   49.59 (-1.51%)
T   38.55 (+0.13%)
ACB   1.93 (-3.02%)
F   8.93 (-0.78%)
NFLX   344.87 (-2.35%)
BAC   33.11 (-1.31%)
DIS   136.96 (-2.23%)
GILD   63.71 (+0.89%)
Log in

OTCMKTS:INSV - Insite Vision Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume650,138 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InSite Vision Incorporated is an ophthalmic product development company that offers ophthalmic pharmaceutical products. The Company's portfolio of products is based on its DuraSite sustained drug delivery technology. The Company's offerings include BromSite and DexaSite. DuraSite sustained drug delivery technology is a synthetic polymer-based formulation to extend the residence time of a drug relative to conventional topical therapies. DuraSite enables topical delivery of a drug as a solution, gel or suspension and can be customized for delivering a variety of drug candidates. The Company is engaged in the research and development and commercial support with the DuraSite drug delivery technology for the following topical products: AzaSite, Besivance, BromSite, DexaSite, AzaSite Plus and ISV-101.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:INSV
CUSIPN/A
Phone+1-510-8658800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive INSV News and Ratings via Email

Sign-up to receive the latest news and ratings for INSV and its competitors with MarketBeat's FREE daily newsletter.


Insite Vision (OTCMKTS:INSV) Frequently Asked Questions

What is Insite Vision's stock symbol?

Insite Vision trades on the OTCMKTS under the ticker symbol "INSV."

Has Insite Vision been receiving favorable news coverage?

Media headlines about INSV stock have trended somewhat negative recently, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Insite Vision earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Insite Vision.

What other stocks do shareholders of Insite Vision own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Insite Vision investors own include Aralez Pharmaceuticals (ARLZ), Novelion Therapeutics (NVLN), Ibio (IBIO) and Portola Pharmaceuticals (PTLA).

How do I buy shares of Insite Vision?

Shares of INSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Insite Vision's official website?

The official website for Insite Vision is http://www.insitevision.com/.

How can I contact Insite Vision?

Insite Vision's mailing address is 965 ATLANTIC AVE, ALAMEDA, CA 94501, United States. The company can be reached via phone at +1-510-8658800.


MarketBeat Community Rating for Insite Vision (OTCMKTS INSV)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  67 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  179
MarketBeat's community ratings are surveys of what our community members think about Insite Vision and other stocks. Vote "Outperform" if you believe INSV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: Bid-Ask Spread

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel